Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?

Cholangiocarcinoma (CCA) is a refractory cancer with limited treatment options and poorly understood molecular mechanisms underlying tumor development. The most effective treatment is surgical resection; however, patients are highly prone to recurrence. Moreover, considering that most patients are d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Xing, Xiaokang, Li, Qijun, Zhang, Ge, Wang, Tao, Pan, Hongming, Li, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378714/
https://www.ncbi.nlm.nih.gov/pubmed/32754231
http://dx.doi.org/10.1177/1758835920940948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378714/
https://www.ncbi.nlm.nih.gov/pubmed/32754231
http://dx.doi.org/10.1177/1758835920940948

Ejemplares similares